REQUEST A DEMO
Total
USD $0.00
Search more companies

Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. is based in Ecuador. The head office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on February 08, 2023. 1 (2024) employees currently work for Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 1093.29% in 2024. There was a total growth of 1294.27% in Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S.’s total assets over the same period. In, 2024, the company’s net profit margin decreased by 2.53%.

Headquarters
Av. Eloy Alfaro
Quito; Pichincha;

Contact Details: Purchase the Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. report to view the information.
Registered Capital:
Purchase the Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. report to view the information.
Financial Auditors:
Purchase the Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. report to view the information.
Incorporation Date:
February 08, 2023
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Infar Company - Industrias Farmaceuticas Ecuatorianas S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1093.29%
Total operating revenue
1093.29%
Operating profit (EBIT)
656.17%
EBITDA
656.17%
Net Profit (Loss) for the Period
121.93%
Total assets
1294.27%
Total equity
11.82%
Operating Profit Margin (ROS)
-12.19%
Net Profit Margin
-2.53%
Return on Equity (ROE)
5.24%
Quick Ratio
2.68%
Cash Ratio
-0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?